As we mark our calendars for World TB Day, a day to raise awareness of tuberculosis around the world, we highlight the importance of collaboration in the field of TB research.
The race to produce COVID-19 vaccines is well underway as they first began appearing on the market at the end of 2020. This accomplishment is the result of unprecedented public-private collaborations and significant investment of public funding in the private development of vaccines and therapeutics.
We conduct collaborative, interdisciplinary research on urgent themes in global health and development: antimicrobial drug resistance, chronic care & aging, the economics of human development, health markets, infectious disease elimination, and urbanization & health.Read More
We accelerate progress on global health and development objectives by sharing knowledge and insights with global agencies, governments, NGOs, and the scientific community.Read More
Rapid diagnostic profiling of SARS-COV-2 in the context of Persistent Immune Activation in Sub-Saharan Africa